Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis

Abstract Background Prevalence of hepatitis C virus (HCV) infection among people who inject drugs (PWID) in Iran is high. Since 2005, the Iranian government has implemented a harm reduction program to control HCV. We aimed to describe the prevalence of HCV antibody (Ab) in Iranian PWID before and af...

Full description

Bibliographic Details
Main Authors: Abdolhalim Rajabi, Heidar Sharafi, Seyed Moayed Alavian
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Harm Reduction Journal
Subjects:
HCV
Online Access:https://doi.org/10.1186/s12954-020-00441-9